# US 2025/0084447 A1 · METHOD FOR PREPARING STABLE ISOTOPE-LABELED ssDNA BY BIOSYNTHESIS WITH ESCHERICHIA COLI

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0084447 A1
- Document ID: US20250084447A1
- Status: Published application
- Kind: A1
- Application number: 18/649,214
- Filed: 2024-04-29
- Published: 2025-03-13
- Earliest claimed: 2023-09-07
- Assignees: East China University of Science and Technology
- Applicants: East China University of Science and Technology
- Inventors: Shenlin Wang; Mengbing Zou; Changxing Ma
- Web page: https://patentgrep.com/patent/US20250084447A1

## CPC

- C12P 19/34: Polynucleotides, e.g. nucleic acids, oligoribonucleotides
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12N 15/66: General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Provided is a method for preparing stable isotope-labeled single-stranded DNA (ssDNA) by biosynthesis with E. coli, and the 15NH4Cl or 13C-Glcose is used as the only nitrogen or carbon source, which may significantly reduce costs. In the method of the present disclosure, the target sequence of ssDNA is tandemly duplicated on a high-copy vector, a site for a first restriction endonuclease and a site for a second restriction endonuclease are added to the 5′ and 3′ ends of the target sequence, respectively, and the recombinant vector is digested to obtain an asymmetric double-stranded DNA structure, which is then isolated by denaturation to obtain two ssDNAs of unequal lengths, including 15N- or 13C-labeled target ssDNA. The method of the present disclosure is able to effectively increase the yield of ssDNA, thereby improving the efficiency of in vitro synthesis of isotope labeled ssDNA.

## Claims

### Claim 1

A method for preparing stable isotope-labeled single-stranded DNA (ssDNA) by biosynthesis with Escherichia coli (E. coli), comprising the steps of:
1) adding a site of a first restriction endonuclease and a site of a second restriction endonuclease to 5′ and 3′ ends of a target sequence, respectively, to obtain a repeating unit; wherein the first restriction endonuclease and the second restriction endonuclease are different;
2) ligating the repeating unit obtained in step 1) in tandem to obtain a fusion sequence;
3) inserting the fusion sequence in step 2) into a high-copy vector to obtain a recombinant vector;
4) introducing the recombinant vector in step 3) into host strain to obtain a recombinant E. coli strain;
5) extracting and purifying the recombinant vector from the recombinant E. coli strain after culture of the recombinant E. coli strain in step 4); where the culture is conducted in a medium with 15NH4Cl as a sole source of nitrogen and/or 13C-glucose as a sole source of carbon;
6) digesting the recombinant vector obtained in step 5) using the first restriction endonuclease and the second restriction endonuclease to obtain an asymmetric double-stranded DNA (dsDNA) structure, and isolating two ssDNAs of unequal lengths, with one of the two ssDNAs as a target sequence; and
7) recovering the target sequence in the two ssDNAs in step 6) to obtain the stable isotope-labeled target ssDNA.

### Claim 2 (depends on 1)

The method according to claim 1, wherein in step 1), the first restriction endonuclease is KpnI and the second restriction endonuclease is BamHI; or, the first restriction endonuclease is KpnI-HF and the second restriction endonuclease is BamHI-HF; or, the first restriction endonuclease is Pst I-HF and the second restriction endonuclease is Hind III-HF; or, the first restriction endonuclease is Kpn I-HF and the second restriction endonuclease is Hind III-HF.

### Claim 3 (depends on 1)

The method according to claim 1, wherein in step 6), the isolating is isolating by urea-polyacrylamide gel electrophoresis.

### Claim 4 (depends on 1)

The method according to claim 1, wherein a short one of the two ssDNAs of unequal lengths in step 6) is a target sequence.

### Claim 5 (depends on 4)

The method according to claim 4, wherein the isolating is isolating by urea-polyacrylamide gel electrophoresis.

### Claim 6 (depends on 1)

The method according to claim 1, wherein in step 2), the ligating is conducted by ligating every 3 to 4 repeating units in tandem as a large repeating unit, and then ligating the large repeating unit in tandem by a linker sequence.

### Claim 7 (depends on 1)

The method according to claim 1, wherein, in step 2), the fusion sequence has a length of not more than 2,000 nt.

### Claim 8 (depends on 7)

The method according to claim 7, wherein in step 2), the ligating is conducted by ligating every 3 to 4 repeating units in tandem as a large repeating unit, and then ligating the large repeating unit in tandem by a linker sequence.

### Claim 9 (depends on 1)

The method according to claim 1, wherein in step 3), the high-copy vector comprises pUC57.

### Claim 10 (depends on 1)

The method according to claim 1, wherein in step 1), the target sequence comprises telomere ssDNA, human c-Myc promoter ssDNA, or human immunodeficiency virus (HIV) ssDNA; the telomere ssDNA has the nucleotide sequence set forth in SEQ ID NO: 1; the human c-Myc promoter ssDNA has the nucleotide sequence set forth in SEQ ID NO: 2; and the HIV ssDNA has the nucleotide sequence set forth in SEQ ID NO: 3.

### Claim 11 (depends on 10)

The method according to claim 10, wherein when the target sequence is telomere ssDNA, the ligating in step 2) is conducted by ligating 12 repeating units in tandem to obtain a fusion sequence;
when the target sequence is human c-Myc promoter ssDNA, the ligating is conducted by ligating 20 repeating units in tandem to obtain the fusion sequence; and
when the target sequence is HIV ssDNA, the ligating is conducted by ligating 15 repeating units in tandem to obtain the fusion sequence.

### Claim 12 (depends on 1)

The method according to claim 1, wherein the 15NH4Cl in the medium in step 5) has a concentration of at least 1 g/L; the 13C-glucose in the medium has a concentration of at least 4 g/L.

### Claim 13 (depends on 1)

The method according to claim 1, wherein step 7) further includes recovering another ssDNA in addition to the target sequence.

### Claim 14 (depends on 1)

A method for preparing a product for screening a medicament targeting HIV long terminal repeat (LTR)-III G-quadruplex (G4), comprising using a stable isotope-labeled ssDNA obtained by the method according to claim 1.

### Claim 15 (depends on 14)

The method according to claim 14, wherein in step 1), the first restriction endonuclease is KpnI and the second restriction endonuclease is BamHI; or, the first restriction endonuclease is KpnI-HF and the second restriction endonuclease is BamHI-HF; or, the first restriction endonuclease is Pst I-HF and the second restriction endonuclease is Hind III-HF; or, the first restriction endonuclease is Kpn I-HF and the second restriction endonuclease is Hind III-HF.

### Claim 16 (depends on 14)

The method according to claim 14, wherein in step 6), the isolating is isolating by urea-polyacrylamide gel electrophoresis.

### Claim 17 (depends on 14)

The method according to claim 14, wherein a short one of the two ssDNAs of unequal lengths in step 6) is a target sequence.

### Claim 18 (depends on 14)

The method according to claim 14, wherein in step 2), the ligating is conducted by ligating every 3 to 4 repeating units in tandem as a large repeating unit, and then ligating the large repeating unit in tandem by a linker sequence.

### Claim 19 (depends on 14)

The method according to claim 14, wherein, in step 2), the fusion sequence has a length of not more than 2,000 nt.

### Claim 20 (depends on 14)

The method according to claim 14, wherein in step 3), the high-copy vector comprises pUC57.
